Discussion: Biosimilars Litigation & Regulation in the EU/UK and U.S.

We are excited to share a video produced in collaboration with Bristows LLP focused on the areas of biosimilars litigation and regulation in the U.S. and EU/UK.

In this video , Overview of Differences Between Governing Schemes for Biosimilars, Dom Adair, Partner at Bristows and Rob Cerwinski, Partner at Goodwin provide an overview of EU/UK and U.S. statutory and regulatory schemes. The video which covers:

  • Marketing and data exclusivities
  • Standards for biosimilarity
  • Interchangeability and substitution
  • Patent litigation resolution schemes
  • Patent office vs. court proceedings